Rhubarb extract targeting liver cancer cells

Can Rhubarb Combat Liver Cancer? The Promising Role of Natural Extracts

Theo Raines monogram
Theo Raines in Health & Wellness November 2026 • 4 min read.

"Emerging research highlights the potential of Rheum palmatum, a natural rhubarb extract, in fighting hepatocellular carcinoma by targeting key cancer signaling pathways."


Hepatocellular carcinoma (HCC), a common and aggressive form of liver cancer, poses a significant global health challenge. Despite advancements in medical treatments, HCC remains a leading cause of cancer-related deaths worldwide. This reality underscores the pressing need for innovative and effective therapeutic strategies.

One promising avenue of exploration lies in the realm of natural compounds, particularly those derived from traditional medicine. For centuries, traditional medicine has offered a rich source of potential remedies, with many modern drugs originating from natural sources. Among these, Rheum palmatum, a species of rhubarb, has garnered attention for its potential anti-cancer properties.

Recent research has begun to uncover the mechanisms through which Rheum palmatum extract exerts its effects on HCC cells. One key area of focus is the signal transducer and activator of transcription 3 (STAT3) pathway, a critical signaling cascade involved in cancer cell growth, survival, and metastasis. Studies suggest that Rheum palmatum extract can disrupt STAT3 signaling, potentially leading to the suppression of HCC development.

AI Search Multiple angles on this topic

Rhubarb’s Anticancer Potential

Research identifies rhubarb anthraquinones (AQs) as potential anti-liver cancer agents, although significant research limitations remain. Key compounds include emodin, rhein, chrysophanol, physcione, and aloe-emodin. Studies report that emodin and aloe-emodin can inhibit cellular proliferation, induce apoptosis, and suppress metastasis, but researchers continue to emphasize balancing toxicity and efficacy.

Unlocking Rhubarb's Potential: How Rheum palmatum Targets Liver Cancer

Rhubarb extract targeting liver cancer cells

A new study investigates the anti-cancer effects of Rheum palmatum extract on hepatocellular carcinoma (HCC) cells. The research focuses on how the extract affects STAT3 signaling, a pathway known to promote cancer cell growth and survival. Researchers treated HCC cell lines with Rheum palmatum extract and observed its impact on cell viability, migration, and invasion.

The study found that Rheum palmatum extract significantly reduced the viability, migration, and invasion of HCC cells. This suggests that the extract has a direct inhibitory effect on cancer cell behavior. Further investigation revealed that the extract suppresses the phosphorylation of STAT3 and its upstream kinases, including JAK2 and Src. Phosphorylation is a crucial step in activating STAT3, so by inhibiting this process, the extract effectively shuts down the signaling pathway.

The key findings of the study include:
  • Reduced viability of HCC cells
  • Inhibition of cell migration and invasion
  • Suppression of STAT3 phosphorylation
  • Downregulation of STAT3 target genes
AI Search Multiple angles on this topic

Recent Findings and Safety Concerns

Recent research reports that rhein has a strong binding affinity for PKM2 and aggravated liver injury in a DEN-induced liver cancer model. Reviews identify rhubarb AQs as containing emodin, rhein, chrysophanol, physcione, and aloe-emodin, while also describing anti-liver cancer activity. However, the literature emphasizes that further experiments are needed to clarify efficacy and establish a safe balance between toxicity and therapeutic effects.

Emodin and STAT3 Signaling

An orthotopic hepatocellular carcinoma study evaluated emodin doses of 25 mg/kg and 50 mg/kg for up to three weeks. The study examined emodin’s ability to inhibit tumor growth and induce apoptosis by blocking STAT3 activation. Separate reporting identifies Rheum palmatum extract and STAT3 inhibition as a promising direction for liver cancer treatment, but these findings remain part of developing research rather than established clinical therapy.

The extract also downregulated several STAT3 target genes, including survivin, Bcl-xL, Mcl-1, and others involved in cell survival, proliferation, and metastasis. Additionally, the study explored the in vivo effects of Rheum palmatum extract in a xenograft tumor model, where the extract suppressed tumor growth and STAT3 activation in tumor tissues. These results indicate that Rheum palmatum extract can effectively target HCC cells both in vitro and in vivo.

The Future of Rhubarb in Cancer Treatment

This research highlights the potential of Rheum palmatum extract as a therapeutic agent for HCC. By inhibiting STAT3 signaling, the extract can suppress cancer cell growth, migration, and invasion. While further studies are needed to fully understand the mechanisms and optimize its use, Rheum palmatum extract offers a promising avenue for developing new and effective liver cancer treatments. The study also paves the way for exploring multi-component and multi-target approaches in cancer therapy, potentially leading to more effective and less toxic treatments.

AI Search Multiple angles on this topic

Unresolved Mechanisms and Toxicity

Recipes containing rhubarb have anti-liver cancer properties and continue to be used. However, the main components responsible for rhubarb’s activity and its mechanisms against liver cancer remain unclear. A review therefore focuses on both the anti-liver cancer effects and the toxicity of rhubarb anthraquinones.

Cell-culture doses in rhubarb-related comparisons

  • 30Emodin induced apoptosis in HepG2 cells at tested concentrations of 30, 60, 90, and 120 μM; the cells also remained in the G1 phase.[1]

How compound findings sit beside extract evidence

Emodin has been described as a principal pharmacodynamic component of rhubarb, and reports across several HCC cell lines link it with inhibited STAT3 activation and nuclear transcription. This offers a compound-level comparison for the extract-focused article, but does not make the findings interchangeable.[2] [3]

STAT3 activity is described as supporting HCC cell survival and growth, while its abnormal activation has also been associated with proliferation, metastasis, and angiogenesis. That context helps explain why effects on this pathway are studied, but pathway relevance alone does not establish clinical efficacy.[4] [5]

What evidence remains unresolved for rhubarb

  • How does the PKM2-related effect of aqueous rhubarb extract arise in the rat liver-cancer model, and how does it relate to the cell findings discussed here?[6]
  • What safety and efficacy evidence in humans would be needed to determine whether findings from cells and animal models translate to people?[7] [8]
  • How can emodin-related liver toxicity be characterized, given reports concerning high doses or long-term use and an unclear mechanism?[9]

Common questions about rhubarb and cancer

Has rhubarb been shown to treat or prevent cancer?

Rhubarb has not been shown to treat or prevent cancer; evidence for safety and efficacy in humans is limited.[7]

Can herbal cancer supplements interact with medicines?

Herbal supplements may have side effects and may interact harmfully with drugs, including cancer treatments.[8]

Terms used in the evidence

STAT3
Signal transducer and activator of transcription 3.[4]
Emodin
A rhubarb-associated compound described as a principal pharmacodynamic component.[2]

Sources

  1. Research Progress on the Anti-Liver Cancer Mechanism and Toxicity of Rhubarb Anthraquinone (pmc.ncbi.nlm.nih.gov)
  2. Advances in the study of emodin: an update on pharmacological properties and mechanistic basis (pmc.ncbi.nlm.nih.gov)
  3. The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers (pmc.ncbi.nlm.nih.gov)
  4. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling. (pubmed.ncbi.nlm.nih.gov)
  5. Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance (pmc.ncbi.nlm.nih.gov)
  6. Aqueous Extract of Rhubarb Promotes Hepatotoxicity via Facilitating PKM2-Mediated Aerobic Glycolysis in a Rat Model of Diethylnitrosamine-Induced Liver Cancer (pmc.ncbi.nlm.nih.gov)
  7. Rhubarb | Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center (www.mskcc.org)
  8. Cancer and Complementary Health Approaches: What You Need To Know | NCCIHNational Center for Complementary and Integrative HealthNational Center for Complementary and Integrative HealthEmailFacebookXX (www.nccih.nih.gov)
  9. Advances in the mechanism of emodin-induced hepatotoxicity. (pubmed.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What exactly is Rheum palmatum, and why is it being studied in relation to liver cancer?

Rheum palmatum is a specific type of rhubarb extract that has shown promise in combating hepatocellular carcinoma (HCC), a common and aggressive form of liver cancer. It's significant because it targets key cancer signaling pathways, particularly the STAT3 pathway, which is crucial for cancer cell growth, survival, and metastasis. By disrupting STAT3 signaling, Rheum palmatum extract can potentially suppress the development and progression of HCC. While other treatments exist, Rheum palmatum offers a potential natural alternative or adjunct therapy.

2

What is the STAT3 pathway, and why is it important in the context of hepatocellular carcinoma (HCC)?

The STAT3 pathway, or signal transducer and activator of transcription 3, is a critical signaling cascade inside cells that promotes cancer cell growth, survival, and metastasis. In HCC, the STAT3 pathway is often overactive, driving the uncontrolled proliferation and spread of cancer cells. Targeting and inhibiting STAT3 signaling with agents like Rheum palmatum extract can disrupt these processes, potentially leading to the suppression of HCC development. It is a key target because interfering with its activity can halt the progression of the disease.

3

How does Rheum palmatum extract actually work to inhibit the STAT3 pathway?

Rheum palmatum extract inhibits the STAT3 pathway by suppressing the phosphorylation of STAT3 and its upstream kinases, including JAK2 and Src. Phosphorylation is essential for activating STAT3, so by preventing this process, Rheum palmatum effectively shuts down the signaling pathway. This, in turn, leads to the downregulation of STAT3 target genes, such as survivin, Bcl-xL, and Mcl-1, which are involved in cell survival, proliferation, and metastasis. This multi-pronged approach helps to reduce the viability, migration, and invasion of HCC cells.

4

What did the research show about the effects of Rheum palmatum extract on liver cancer cells?

The research demonstrated that Rheum palmatum extract reduced the viability, migration, and invasion of hepatocellular carcinoma (HCC) cells in laboratory settings (in vitro). Further, in animal studies using xenograft tumor models (in vivo), the extract suppressed tumor growth and STAT3 activation in tumor tissues. These results suggest that Rheum palmatum extract can effectively target HCC cells, slowing tumor progression. However, these results need to be confirmed in human clinical trials.

5

What are the potential implications of this research for the future of liver cancer treatment?

The findings suggest a potential new avenue for developing effective liver cancer treatments, with less toxic side effects due to the natural origin of the extract. This research paves the way for exploring multi-component and multi-target approaches to cancer therapy. This could mean combining Rheum palmatum with other treatments or targeting multiple pathways simultaneously for a more comprehensive approach. However, significant further research is needed before Rheum palmatum can be used clinically.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.